Insights on Intestinal Fibrosis: From Stromal Cell Heterogeneity and Metabolic Reprogramming to Novel Therapeutic Strategies

Intestinal fibrosis is a major complication of inflammatory bowel disease, and it can lead to fixed strictures, intestinal obstruction, and repeated surgical intervention. Although effective control of inflammation may limit ongoing tissue injury, no approved therapy selectively prevents or reverses established intestinal fibrosis. This therapeutic gap reflects an incomplete understanding of the cellular and metabolic mechanisms that sustain fibrotic remodeling. In this review, we integrate classical extracellular-matrix pathways with recent single-cell, spatial, and metabolic evidence to provide a multicellular framework for intestinal fibrogenesis. Single-cell studies indicate that intestinal fibroblasts comprise overlapping and environmentally responsive states rather than fixed lineages. Their activation is shaped by reciprocal communication with immune cells, epithelial and endothelial cells, smooth muscle cells, creeping fat, and the intestinal microbiota. Metabolic reprogramming provides an additional layer of regulation through glycolysis, pentose phosphate pathway, glutamine–proline metabolism, lactate-associated signaling, and extracellular metabolite sensing. However, the strength of evidence varies among these mechanisms, and direct links between defined fibroblast states and specific metabolic dependencies remain limited. In this review, we further discuss therapeutic opportunities targeting immune–stromal communication, pathogenic fibroblast programs, cellular metabolism, extracellular-matrix turnover, and mechanotransduction. Translating these opportunities into stage-specific interventions will require spatially resolved functional models to validate causal targets and fibrosis-selective biomarkers to assess therapeutic effects.

Authors

Institutions

Publication Details

Journal
Cells
Published
2026-11-20
DOI
https://doi.org/10.3390/cells15222118
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Insights on Intestinal Fibrosis: From Stromal Cell Heterogeneity and Metabolic Reprogramming to Novel Therapeutic Strategies

Jin Wang, Y Zhang, Xiuli Bi, Xiaoqin Bai et al.
2 links
Cells
Inflammatory Bowel Disease
article

Insights on Intestinal Fibrosis: From Stromal Cell Heterogeneity and Metabolic Reprogramming to Novel Therapeutic Strategies

Jin Wang, Y Zhang, Xiuli Bi, Xiaoqin Bai, Rongji Xu, Yue Liu
article en

Abstract

Intestinal fibrosis is a major complication of inflammatory bowel disease, and it can lead to fixed strictures, intestinal obstruction, and repeated surgical intervention. Although effective control of inflammation may limit ongoing tissue injury, no approved therapy selectively prevents or reverses established intestinal fibrosis. This therapeutic gap reflects an incomplete understanding of the cellular and metabolic mechanisms that sustain fibrotic remodeling. In this review, we integrate classical extracellular-matrix pathways with recent single-cell, spatial, and metabolic evidence to provide a multicellular framework for intestinal fibrogenesis. Single-cell studies indicate that intestinal fibroblasts comprise overlapping and environmentally responsive states rather than fixed lineages. Their activation is shaped by reciprocal communication with immune cells, epithelial and endothelial cells, smooth muscle cells, creeping fat, and the intestinal microbiota. Metabolic reprogramming provides an additional layer of regulation through glycolysis, pentose phosphate pathway, glutamine–proline metabolism, lactate-associated signaling, and extracellular metabolite sensing. However, the strength of evidence varies among these mechanisms, and direct links between defined fibroblast states and specific metabolic dependencies remain limited. In this review, we further discuss therapeutic opportunities targeting immune–stromal communication, pathogenic fibroblast programs, cellular metabolism, extracellular-matrix turnover, and mechanotransduction. Translating these opportunities into stage-specific interventions will require spatially resolved functional models to validate causal targets and fibrosis-selective biomarkers to assess therapeutic effects.

CellsVol. 15(22)
Liaoning University (CN)
Liaoning Revitalization Talents Program
Good health and well-being
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Insights on Intestinal Fibrosis: From Stromal Cell Heterogeneity and Metabolic Reprogramming to Novel Therapeutic Strategies — Jin Wang, Y Zhang, et al. · Cells (2026) | TGRS Research Map | TGRS